J Neurol Neurosurg Psychiatry 81:e25-e26 doi:10.1136/jnnp.2010.226340.35
  • ABN Abstracts

PATU6 Protein interactors of EAAT2 and their role in motor neurone disease/amyotrophic lateral sclerosis

  1. C Moorby
  1. University of Birmingham, Birmingham, UK
  1. Correspondence to k.morrison{at}


Glutamate excitotoxicity has been implicated in numerous neurodegenerative diseases, including motor neurone disease, MND/ALS. The glutamate transporter EAAT2 is the primary regulator of extracellular glutamate concentration and specific reductions in its expression and transport function have been reported in MND patients and rodent models of the disease. Previous studies have detected no abnormalities in the genomic DNA or mRNA of EAAT2 in MND patients. We now hypothesise that abnormalities in protein interactors of EAAT2 may cause its dysfunction in MND. Using yeast 2-hybrid screening followed by mammalian co-localisation and co-immunoprecipitation experiments, we have identified four novel protein interactors of EAAT2. We have undertaken a genetic screen of the exons of one of these interactors in 100 MND patients and 100 age-matched control individuals. Of interest, we identified single nucleotide variants that are predicted to alter the amino acid sequence in 24% of the ALS patients, compared to 4% of the controls, a highly statistically significant difference. These results suggest that genetic variants in this EAAT2 interacting gene are susceptibility factors for MND. Functional studies on this novel interactor are now required to assess the impact of these variants on EAAT2 function and shed light on their possible role in MND pathogenesis.

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article